发明名称 |
Compositions and methods to evaluate hepatobiliary/gastrointestinal health, enterohepatic circulation, and drug interactions |
摘要 |
The present invention relates to the synthesis and use of a novel trifluorinated bile acid analog, that being, CA-sar-TFMA which is useful as an imaging probe, diagnostic agent or contrast agent and is resistant to bacterial deconjugation, wherein the trifluorinated bile acid analog can be used as a 19F MRI tracer exhibiting an increased half-life due to its resistance to choloylglycine hydrolase. |
申请公布号 |
US9597417(B2) |
申请公布日期 |
2017.03.21 |
申请号 |
US201414535397 |
申请日期 |
2014.11.07 |
申请人 |
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMETN OF VETERANS AFFAIRS |
发明人 |
Polli James E.;Raufman Jean-Pierre;Vivian Diana |
分类号 |
A61K49/08;A61K31/56;A61K49/10 |
主分类号 |
A61K49/08 |
代理机构 |
Moore & Van Allen, PLLC |
代理人 |
Fuierer Marianne;Moore & Van Allen, PLLC |
主权项 |
1. A trifluorinated bile acid analogue compound having the following structure: wherein the trifluorinated bile acid analogue compound is a 19F magnetic resonance imaging probe. |
地址 |
Washington DC US |